368 related articles for article (PubMed ID: 27127176)
1. Tumour-associated circulating microparticles: A novel liquid biopsy tool for screening and therapy monitoring of colorectal carcinoma and other epithelial neoplasia.
Willms A; Müller C; Julich H; Klein N; Schwab R; Güsgen C; Richardsen I; Schaaf S; Krawczyk M; Krawczyk M; Lammert F; Schuppan D; Lukacs-Kornek V; Kornek M
Oncotarget; 2016 May; 7(21):30867-75. PubMed ID: 27127176
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma.
Julich-Haertel H; Urban SK; Krawczyk M; Willms A; Jankowski K; Patkowski W; Kruk B; Krasnodębski M; Ligocka J; Schwab R; Richardsen I; Schaaf S; Klein A; Gehlert S; Sänger H; Casper M; Banales JM; Schuppan D; Milkiewicz P; Lammert F; Krawczyk M; Lukacs-Kornek V; Kornek M
J Hepatol; 2017 Aug; 67(2):282-292. PubMed ID: 28267620
[TBL] [Abstract][Full Text] [Related]
3. Single tube liquid biopsy for advanced non-small cell lung cancer.
de Wit S; Rossi E; Weber S; Tamminga M; Manicone M; Swennenhuis JF; Groothuis-Oudshoorn CGM; Vidotto R; Facchinetti A; Zeune LL; Schuuring E; Zamarchi R; Hiltermann TJN; Speicher MR; Heitzer E; Terstappen LWMM; Groen HJM
Int J Cancer; 2019 Jun; 144(12):3127-3137. PubMed ID: 30536653
[TBL] [Abstract][Full Text] [Related]
4. Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions.
Roca E; Lacroix R; Judicone C; Laroumagne S; Robert S; Cointe S; Muller A; Kaspi E; Roll P; Brisson AR; Tantucci C; Astoul P; Dignat-George F
Oncotarget; 2016 Jan; 7(3):3357-66. PubMed ID: 26689993
[TBL] [Abstract][Full Text] [Related]
5. Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention.
Tseng CC; Wang CC; Hsiao CC; Lu HI; Leu S; Chang HC; Huang KT; Fang WF; Chen YM; Liu SF; Yang CT; Lin MC; Yip HK
Tumour Biol; 2016 Sep; 37(9):11873-11882. PubMed ID: 27059732
[TBL] [Abstract][Full Text] [Related]
6. Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application.
Yin J; Wang Y; Yin H; Chen W; Jin G; Ma H; Dai J; Chen J; Jiang Y; Wang H; Liu Z; Hu Z; Shen H
PLoS One; 2015; 10(8):e0137076. PubMed ID: 26317979
[TBL] [Abstract][Full Text] [Related]
7. EpCAM-expressing circulating tumor cells in colorectal cancer.
Nicolazzo C; Raimondi C; Francescangeli F; Ceccarelli S; Trenta P; Magri V; Marchese C; Zeuner A; Gradilone A; Gazzaniga P
Int J Biol Markers; 2017 Oct; 32(4):e415-e420. PubMed ID: 28604994
[TBL] [Abstract][Full Text] [Related]
8. Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer.
Chen L; Peng M; Li N; Song Q; Yao Y; Xu B; Liu H; Ruan P
Sci Rep; 2018 Jan; 8(1):1188. PubMed ID: 29352248
[TBL] [Abstract][Full Text] [Related]
9. Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients.
Liu S; Tian Z; Zhang L; Hou S; Hu S; Wu J; Jing Y; Sun H; Yu F; Zhao L; Wang R; Tseng HR; Zhau HE; Chung LW; Wu K; Wang H; Wu JB; Nie Y; Shao C
Oncotarget; 2016 Sep; 7(37):59877-59891. PubMed ID: 27494883
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cell clusters are a potential biomarker for detection of non-small cell lung cancer.
Manjunath Y; Upparahalli SV; Suvilesh KN; Avella DM; Kimchi ET; Staveley-O'Carroll KF; Li G; Kaifi JT
Lung Cancer; 2019 Aug; 134():147-150. PubMed ID: 31319973
[TBL] [Abstract][Full Text] [Related]
11. [What future for circulating tumor DNA? Current data and prospects in colorectal, non-small cell lung and pancreatic cancers].
Pietrasz D; Pécuchet N; Fabre E; Blons H; Chevalier L; Taly V; Laurent-Puig P; Bachet JB
Bull Cancer; 2016 Jan; 103(1):55-65. PubMed ID: 26790710
[TBL] [Abstract][Full Text] [Related]
12. The expression of circulating tumor cells in peripheral blood of patients with non-small cell lung cancer and its detection.
Bu XM; Xu FF; Ma J; Jiang B
J Biol Regul Homeost Agents; 2018; 32(4):843-849. PubMed ID: 30043565
[TBL] [Abstract][Full Text] [Related]
13. Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer.
Mariscal J; Alonso-Nocelo M; Muinelo-Romay L; Barbazan J; Vieito M; Abalo A; Gomez-Tato A; Maria de Los Angeles CC; Garcia-Caballero T; Rodriguez C; Brozos E; Baron F; Lopez-Lopez R; Abal M
Sci Rep; 2016 Nov; 6():37820. PubMed ID: 27901069
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9) levels in colorectal cancer patients and correlation with clinicopathological characteristics.
Mourtzikou A; Stamouli M; Kroupis C; Christodoulou S; Skondra M; Kastania A; Pectasides D; Athanasas G; Dimas C
Clin Lab; 2012; 58(5-6):441-8. PubMed ID: 22783573
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin 19, carcinoembryonic antigen, and epithelial cell adhesion molecule detect lung cancer lymph node metastasis in endobronchial ultrasound-guided transbronchial aspiration samples.
Bugalho A; Martins C; Dias SS; Nunes G; Silva Z; Correia M; Marques Gomes MJ; Videira PA
Clin Lung Cancer; 2013 Nov; 14(6):704-12. PubMed ID: 23886796
[TBL] [Abstract][Full Text] [Related]
16. The origin and concentration of circulating microparticles differ according to cancer type and evolution: A prospective single-center study.
Mege D; Panicot-Dubois L; Ouaissi M; Robert S; Sielezneff I; Sastre B; Dignat-George F; Dubois C
Int J Cancer; 2016 Feb; 138(4):939-48. PubMed ID: 26341361
[TBL] [Abstract][Full Text] [Related]
17. A negative selection system PowerMag for effective leukocyte depletion and enhanced detection of EpCAM positive and negative circulating tumor cells.
Lin HC; Hsu HC; Hsieh CH; Wang HM; Huang CY; Wu MH; Tseng CP
Clin Chim Acta; 2013 Apr; 419():77-84. PubMed ID: 23415697
[TBL] [Abstract][Full Text] [Related]
18. Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer.
Fleitas T; Martínez-Sales V; Vila V; Reganon E; Mesado D; Martín M; Gómez-Codina J; Montalar J; Reynés G
PLoS One; 2012; 7(10):e47365. PubMed ID: 23077602
[TBL] [Abstract][Full Text] [Related]
19. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.
Bracht JWP; Mayo-de-Las-Casas C; Berenguer J; Karachaliou N; Rosell R
Curr Oncol Rep; 2018 Jul; 20(9):70. PubMed ID: 30030656
[TBL] [Abstract][Full Text] [Related]
20. Development of a membrane array-based multimarker assay for detection of circulating cancer cells in patients with non-small cell lung cancer.
Sheu CC; Yu YP; Tsai JR; Chang MY; Lin SR; Hwang JJ; Chong IW
Int J Cancer; 2006 Sep; 119(6):1419-26. PubMed ID: 16642481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
